Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Clostridium Butyricum MIYAIRI |
?
[Antagonistic interaction between Clostridium butyricum and enterohemorrhagic Escherichia coli O157:H7]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases (Kansenshogaku Zasshi ) Vol: 73 Issue 1 Pages: 7-14 Pub: 1999 Jan Epub: Authors Takahashi M , Taguchi H , Yamaguchi H , Osaki T , Sakazaki R , Kamiya S , Publication |
| Clostridium Butyricum MIYAIRI |
?
The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis. Surgery today (Surg Today ) Vol: 46 Issue 8 Pages: 939-49 Pub: 2016 Aug Epub: 2015 Oct 29 Authors Yasueda A , Mizushima T , Nezu R , Sumi R , Tanaka M , Nishimura J , Kai Y , Hirota M , Osawa H , Nakajima K , Mori M , Ito T , Publication |
| Clostridium Butyricum MIYAIRI |
?
Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 6927 Pub: 2017 Jul 31 Epub: 2017 Jul 31 Authors Shi D , Lv L , Fang D , Wu W , Hu C , Xu L , Chen Y , Guo J , Hu X , Li A , Guo F , Ye J , Li Y , Andayani D , Li L , Html Article Publication |
| Clostridium Butyricum MIYAIRI |
?
Galleria mellonella as an in vivo model for assessing the protective activity of probiotics against gastrointestinal bacterial pathogens. FEMS microbiology letters (FEMS Microbiol Lett ) Vol: 364 Issue 7 Pages: Pub: 2017 Apr 1 Epub: Authors Scalfaro C , Iacobino A , Nardis C , Franciosa G , Publication |
| Clostridium Butyricum MIYAIRI |
?
[Intestinal Care Using L?Glutamine Supplement and Probiotics Can Induce a Strong Anti?Tumor Immune Response through the Induction of Mature Tertiary Lymphoid Structures in Pancreatic Cancer Patients Receiving Preoperative Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho ) Vol: 48 Issue 4 Pages: 465-471 Pub: 2021 Apr Epub: Authors Ohta T , Makino I , Okazaki M , Miyashita T , Tajima H , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.